InvestorsHub Logo
icon url

Gator328

11/30/22 9:53 AM

#386342 RE: ExtremelyBullishZig #386341

Okay.

I'd still think the fastest path, even with a few month delay, is to get Rett approved and use the voucher to accelerate approval for Blarcamesine. Even though we may think it's the most important drug in the FDA's docket, the FDA may not feel it's as big of a priority as say, a new cancer drug that requires the same amount of manpower to review.

I'd rather have the voucher and know that Anavex will be escorted to the front of the review process line.
icon url

rx7171

11/30/22 2:32 PM

#386522 RE: ExtremelyBullishZig #386341

But that voucher could be used to get an accelerated approval of the AD NDA.
Bullish
Bullish